Hiromi Okigami

Summary

Affiliation: Nara Women's University
Country: Japan

Publications

  1. ncbi Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4
    Hiromi Okigami
    Bayer Yakuhin, Ltd, Research Center Kyoto, Respiratory Disease Research, Japan
    Eur J Pharmacol 559:202-9. 2007
  2. ncbi Discovery and evaluation of terephthalic acid derivatives as potent alpha4beta1 integrin antagonists
    Gerhard Muller
    Bayer AG, Central Research, Building Q18, D 51368 Leverkusen, Germany
    J Enzyme Inhib Med Chem 18:309-12. 2003

Collaborators

  • Gerhard Muller
  • Thomas E Lehmann
  • Thomas Rölle
  • Masaomi Tajimi
  • Markus Albers
  • Kevin Bacon
  • Gerhard Hessler

Detail Information

Publications2

  1. ncbi Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4
    Hiromi Okigami
    Bayer Yakuhin, Ltd, Research Center Kyoto, Respiratory Disease Research, Japan
    Eur J Pharmacol 559:202-9. 2007
    ..These data support the use of small molecule VLA-4 antagonists in the treatment of relevant diseases, such as asthma, atopic dermatitis, or allergic rhinitis...
  2. ncbi Discovery and evaluation of terephthalic acid derivatives as potent alpha4beta1 integrin antagonists
    Gerhard Muller
    Bayer AG, Central Research, Building Q18, D 51368 Leverkusen, Germany
    J Enzyme Inhib Med Chem 18:309-12. 2003
    ..The compounds 2, 10-12, 14, and 16-17 inhibited the adhesion in a cell based assay in the low and sub micromolar range...